Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Development of a human vasopressin V1a-receptor antagonist from an evolutionary-related insect neuropeptide

MG. Di Giglio, M. Muttenthaler, K. Harpsøe, Z. Liutkeviciute, P. Keov, T. Eder, T. Rattei, S. Arrowsmith, S. Wray, A. Marek, T. Elbert, PF. Alewood, DE. Gloriam, CW. Gruber,

. 2017 ; 7 (-) : 41002. [pub] 20170201

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Characterisation of G protein-coupled receptors (GPCR) relies on the availability of a toolbox of ligands that selectively modulate different functional states of the receptors. To uncover such molecules, we explored a unique strategy for ligand discovery that takes advantage of the evolutionary conservation of the 600-million-year-old oxytocin/vasopressin signalling system. We isolated the insect oxytocin/vasopressin orthologue inotocin from the black garden ant (Lasius niger), identified and cloned its cognate receptor and determined its pharmacological properties on the insect and human oxytocin/vasopressin receptors. Subsequently, we identified a functional dichotomy: inotocin activated the insect inotocin and the human vasopressin V1b receptors, but inhibited the human V1aR. Replacement of Arg8 of inotocin by D-Arg8 led to a potent, stable and competitive V1aR-antagonist ([D-Arg8]-inotocin) with a 3,000-fold binding selectivity for the human V1aR over the other three subtypes, OTR, V1bR and V2R. The Arg8/D-Arg8 ligand-pair was further investigated to gain novel insights into the oxytocin/vasopressin peptide-receptor interaction, which led to the identification of key residues of the receptors that are important for ligand functionality and selectivity. These observations could play an important role for development of oxytocin/vasopressin receptor modulators that would enable clear distinction of the physiological and pathological responses of the individual receptor subtypes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19001327
003      
CZ-PrNML
005      
20190108130323.0
007      
ta
008      
190107s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/srep41002 $2 doi
035    __
$a (PubMed)28145450
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Di Giglio, Maria Giulia $u Center for Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria.
245    10
$a Development of a human vasopressin V1a-receptor antagonist from an evolutionary-related insect neuropeptide / $c MG. Di Giglio, M. Muttenthaler, K. Harpsøe, Z. Liutkeviciute, P. Keov, T. Eder, T. Rattei, S. Arrowsmith, S. Wray, A. Marek, T. Elbert, PF. Alewood, DE. Gloriam, CW. Gruber,
520    9_
$a Characterisation of G protein-coupled receptors (GPCR) relies on the availability of a toolbox of ligands that selectively modulate different functional states of the receptors. To uncover such molecules, we explored a unique strategy for ligand discovery that takes advantage of the evolutionary conservation of the 600-million-year-old oxytocin/vasopressin signalling system. We isolated the insect oxytocin/vasopressin orthologue inotocin from the black garden ant (Lasius niger), identified and cloned its cognate receptor and determined its pharmacological properties on the insect and human oxytocin/vasopressin receptors. Subsequently, we identified a functional dichotomy: inotocin activated the insect inotocin and the human vasopressin V1b receptors, but inhibited the human V1aR. Replacement of Arg8 of inotocin by D-Arg8 led to a potent, stable and competitive V1aR-antagonist ([D-Arg8]-inotocin) with a 3,000-fold binding selectivity for the human V1aR over the other three subtypes, OTR, V1bR and V2R. The Arg8/D-Arg8 ligand-pair was further investigated to gain novel insights into the oxytocin/vasopressin peptide-receptor interaction, which led to the identification of key residues of the receptors that are important for ligand functionality and selectivity. These observations could play an important role for development of oxytocin/vasopressin receptor modulators that would enable clear distinction of the physiological and pathological responses of the individual receptor subtypes.
650    _2
$a substituce aminokyselin $7 D019943
650    _2
$a zvířata $7 D000818
650    _2
$a antagonisté antidiuretického hormonu $x izolace a purifikace $x metabolismus $7 D065092
650    _2
$a Formicidae $7 D001000
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a lidé $7 D006801
650    _2
$a neuropeptidy $x genetika $x izolace a purifikace $x metabolismus $7 D009479
650    _2
$a vazba proteinů $7 D011485
650    _2
$a receptory vasopresinů $x agonisté $7 D017483
650    _2
$a rekombinantní proteiny $x genetika $x izolace a purifikace $x metabolismus $7 D011994
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Muttenthaler, Markus $u Institute for Molecular Bioscience, The University of Queensland, QLD 4072 Brisbane, Australia.
700    1_
$a Harpsøe, Kasper $u Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 162, 2100 Copenhagen, Denmark.
700    1_
$a Liutkeviciute, Zita $u Center for Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria.
700    1_
$a Keov, Peter $u School of Biomedical Sciences, The University of Queensland, QLD 4072 Brisbane, Australia.
700    1_
$a Eder, Thomas $u IST Austria (Institute of Science and Technology), Am Campus 1, 3400 Klosterneuburg, Austria. CUBE-Division of Computational Systems Biology, Department of Microbiology and Ecosystem Science, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.
700    1_
$a Rattei, Thomas $u CUBE-Division of Computational Systems Biology, Department of Microbiology and Ecosystem Science, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.
700    1_
$a Arrowsmith, Sarah $u Harris-Wellbeing Preterm Birth Research Centre, Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, L69 3BX, United Kingdom.
700    1_
$a Wray, Susan $u Harris-Wellbeing Preterm Birth Research Centre, Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, L69 3BX, United Kingdom.
700    1_
$a Marek, Ales $u Laboratory of Radioisotopes, Institute of Organic Chemistry and Biochemistry CAS, Flemingovo nám. 2, CZ-16610 Prague 6, Czech Republic.
700    1_
$a Elbert, Tomas $u Laboratory of Radioisotopes, Institute of Organic Chemistry and Biochemistry CAS, Flemingovo nám. 2, CZ-16610 Prague 6, Czech Republic.
700    1_
$a Alewood, Paul F $u Institute for Molecular Bioscience, The University of Queensland, QLD 4072 Brisbane, Australia.
700    1_
$a Gloriam, David E $u Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 162, 2100 Copenhagen, Denmark.
700    1_
$a Gruber, Christian W $u Center for Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria. School of Biomedical Sciences, The University of Queensland, QLD 4072 Brisbane, Australia.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. - (2017), s. 41002
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28145450 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190108130524 $b ABA008
999    __
$a ok $b bmc $g 1365211 $s 1039450
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 7 $c - $d 41002 $e 20170201 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...